Bakkt Announced Caesars Rewards Members Will Soon Be Able To Redeem Rewards Credits Through Bakkt Crypto Rewards
Bakkt Holdings, Inc. ("Bakkt"), a technology platform that enables partners to unlock crypto and drive loyalty, today announced a deal with Caesars Entertainment ("Caesars"), the largest casino-entertainment company in the U.S. To launch this pairing, the state-of-the-art live entertainment venue at Planet Hollywood Resort & Casino, formerly known as Zappos Theater, will be renamed Bakkt Theater.
Corteva Agriscience and Bunge Announced Collaboration to Develop Amino Acid-Enhanced Soybeans
Corteva Inc. (NYSE: CTVA), and Bunge (NYSE: BG) announced today significant advancements in the development of more nutritious soybean meal for the animal feed industry, specifically suited for poultry, swine and aqua feed.
Taiwan Semiconductor Keeps Fab Utilization Rate at 70% or Higher
-DigiTimes
https://www.digitimes.com/news/a20230308PD216/3nm-5nm-7nm-tsmc.html
Wall Street Journal Reported Baidu Is Set To Launch Its Ernie Bot On March 16, Relying On Nvidia A100 Chips For Training
https://www.wsj.com/articles/baidu-scrambles-to-ready-chinas-first-chatgpt-equivalent-ahead-of-launch-bf359ca4
Oncternal Therapeutics Filed U.S. Patent Application: Combinations Of EFGR Inhibitors And ROR1 Inhibitors For The Treatment Of Cancer
https://www.scribd.com/document/630357588/ONCT-Patent-Application
Kinnate Biopharma Filed U.S. Patent Application #20230074545: Treatment Of Cancer With CDK12/13 Inhibitors
https://www.scribd.com/document/630356754/KNTE-Patent-Application
Infosys Announced Collaboration with Mobility Specialist ZF to Revamp Supply Chain Operations
Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY) , today announced that it has collaborated with mobility specialist ZF to revamp its multi-echelon supply chain with SAP Integrated Business Planning® (SAP IBP) and Infosys Cobalt.
AstraZeneca Announced Earlier: Imfinzi improved Event-free Survival In Resectable Lung Cancer
Positive high-level results from a planned interim analysis of the AEGEAN Phase III, placebo- controlled trial showed that treatment with AstraZeneca's Imfinzi (durvalumab) in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery demonstrated a statistically significant and clinically meaningful improvement in event-free survival (EFS) versus neoadjuvan
FTX Reaches $45M Deal to Sell Interest in Sequoia to Abu Dhabi’s Investment Arm
-CoinDesk
https://www.coindesk.com/business/2023/03/09/ftx-reaches-45m-deal-to-sell-interest-in-sequoia-to-abu-dhabis-investment-arm/